文献速递临床试验与 GCP基础与转化研究

配伍穴位与单穴对比假针刺治疗功能性消化不良的随机对照试验方案

Efficacy of compatible acupoints and single acupoint versus sham acupuncture for functional dyspepsia: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-01-14

BACKGROUND: Acupoint selection is a key factor in the treatment of diseases and has not been well studied. The aim of this trial is to explore the differences in efficacy between compatible acupoints and a single acupoint for patients with functional dyspepsia (FD).…

要点

  • 主要结局为4周治疗前后尼平消化不良生活质量指数变化。
  • 治疗4周共20次针刺,随访4周,并检测超弱光子发射与代谢组学。

核心结论

  • 该试验将比较配伍穴位与单穴治疗功能性消化不良的疗效差异。

研究设计与样本

  • 试验含1周基线期、4周治疗期和4周随访期,治疗期共20次针刺。

关键数值与推荐

  • 主要结局为尼平消化不良生活质量指数从基线至4周治疗结束的变化。
  • 次要结局包括消化不良症状总分、整体治疗效应问卷和36项简表调查,并记录不良事件。

临床怎么用

  • 结果将用于比较配伍穴位与单穴治疗功能性消化不良的疗效差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acupoint selection is a key factor in the treatment of diseases and has not been well studied. The aim of this trial is to explore the differences in efficacy between compatible acupoints and a single acupoint for patients with functional dyspepsia (FD). METHODS: This randomized controlled trial will be conducted in the First Affiliated Hospital of Changchun University of Chinese Medicine in China. Two hundred and sixteen FD patients will be randomly assigned to the compatible acupoints group, single acupoint group, or sham acupuncture group. This trial will include a 1-week baseline period, a 4-week treatment period, and a 4-week follow-up period. During the 4-week treatment period, patients will receive 20 sessions of acupuncture (weekly cycles of one session per day for 5 consecutive days followed by a 2-day break). The primary outcome will be a change in the Nepean Dyspepsia Life Quality Index from baseline to after the 4-week treatment period. Secondary outcome measures will include the dyspeptic symptom sum score, Overall Treatment Effect questionnaire, and 36-item Short Form survey. Adverse events also will be recorded. Ultraweak photon emission and metabolomics tests will be performed at baseline and at the end of treatment to explore the mechanisms of the differences between compatible acupoints and a single acupoint. DISCUSSION: The results of this trial will allow us to compare the difference in efficacy between compatible acupoints and a single acupoint. The findings from this trial will be published in peer-reviewed journals. TRIAL REGISTRATION: Acupuncture-Moxibustion Clinical Trial Registry, AMCTR-IPC-18000176, registered on 4 March 2019; Chinese Clinical Trial Registry, ChiCTR1900023983, registered on 23 June 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Guo L, Huang X, Ha LJ, et al. Efficacy of compatible acupoints and single acupoint versus sham acupuncture for functional dyspepsia: study protocol for a randomized controlled trial. Trials. 2020. PMID: 31937335. doi:10.1186/s13063-019-3875-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。